Investor Relations

Latest Financial Results

Latest Annual Filing

For Fiscal Year Ending Aug 31, 2019

Company Overview

Artelo Biosciences, Inc. is a San Diego-based biopharmaceutical company dedicated to the development and commercialization of proprietary therapeutics targeting the endocannabinoid system. Artelo is rapidly advancing a portfolio of broadly applicable product candidates designed to address significant unmet needs in multiple diseases and conditions, including anorexia, cancer, pain, and inflammation. Led by proven biopharmaceutical executives collaborating with highly respected researchers and technology experts, the Company applies leading edge scientific, regulatory, and commercial discipline to develop high-impact therapies.

Investor Contact Information

Company

Artelo Biosciences, Inc.
888 Prospect Street
Suite 210
La Jolla, CA 92037

Investor Relations

Crescendo Communications, LLC
T: 212-671-1020
ARTL@crescendo-ir.com

Transfer Agent

Globex Transfer, LLC
780 Deltona Blvd.
Suite 202
Deltona, FL 32725